LIBCUVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jul 2024)
What this means for you
This application is over — abandoned 08 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97757459
- Mark type
- Design + words
- Filed
- 17 Jan 2023
- Published for opposition
- 10 Oct 2023
- Abandoned
- 08 Jul 2024
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 24 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Oct 2023 — PUBLISHED FOR OPPOSITION
- 20 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE